Prescription drug · NDA
Alphagan P (Brimonidine tartrate) NDC 0023-9177
Brimonidine tartrate 1.5 mg/mL · Solution/ drops · Ophthalmic · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0023-9177-05 | 0002391770500023917705 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Jul 10, 2001 | |
| 0023-9177-10 | 0002391771000023917710 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from Jul 10, 2001 | |
| 0023-9177-15 | 0002391771500023917715 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-15) / 15 mL in 1 BOTTLE, DROPPERMarketed from Jul 10, 2001 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Alphagan P
- Generic name (nonproprietary)
- brimonidine tartrate
- Active ingredients
- Brimonidine tartrate — 1.5 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Allergan, Inc.NDC labeler code 0023
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021262
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Agonists (Mechanism)
- Identifiers
- Product ID 0023-9177_d93b4518-c444-4a54-ba55-1fbfc7542911SPL ID d93b4518-c444-4a54-ba55-1fbfc7542911SPL set ID 264c4494-c225-486f-888a-caaf36be46b3RxCUI 861204, 861206, 861208, 861210UNII 4S9CL2DY2HUPC 0300239177109
- Pharmacologic class
- alpha-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400023917705followed by a unit qualifier and the quantityPackage 00023-9177-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ALPHAGAN P (brimonidine tartrate ophthalmic solution) 0.1% or 0.15% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ALPHAGAN P is an alpha adrenergic agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0023-9177
- What is NDC 0023-9177?
- 0023-9177 is the product NDC for Alphagan P (brimonidine tartrate), Brimonidine tartrate 1.5 mg/mL solution/ drops, listed with the FDA by Allergan, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Alphagan P (Brimonidine tartrate).
- What is the active ingredient?
- Brimonidine tartrate.
- Who is the labeler?
- Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Alphagan P?
- 1 other product NDC are listed under this name. See all Alphagan P NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Alphagan P products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Alphagan Pbrimonidine tartrate | Brimonidine tartrate 1 mg/mL | Solution/ dropsOphthalmic | Allergan, Inc. | 0023-9321 | 00023-9321-0300023-9321-0500023-9321-10+1 more |
Other NDCs under NDA 021262
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Brimonidine tartrate | Brimonidine tartrate 1.5 mg/mL | Solution/ dropsOphthalmic | Pacific Pharma, Inc. | 82182-773 |